| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥603.8B | ¥613.7B | -1.6% |
| Operating Income | ¥63.5B | ¥74.2B | -14.5% |
| Ordinary Income | ¥60.0B | ¥68.5B | -12.4% |
| Net Income | ¥45.5B | ¥49.7B | -8.6% |
| ROE | 12.2% | 15.4% | - |
FY2026 Q3 cumulative results showed Revenue of 603.8B yen (YoY -1.6%), Operating Income of 63.5B yen (YoY -14.5%), Ordinary Income of 60.0B yen (YoY -12.4%), and Net Income of 45.5B yen (YoY -8.6%). While gross profit margin remained robust at 49.2%, SG&A expenses of 233.5B yen constrained profitability, resulting in an operating margin of 10.5%, down from the prior year. The company maintained a healthy ROE of 12.2%, supported by net profit margin of 7.5%, asset turnover of 0.749, and financial leverage of 2.17x. However, operating profit declined more sharply than revenue, indicating operating leverage deterioration driven by elevated SG&A costs and operational inefficiencies. Cash and deposits stood at 172.4B yen, providing adequate liquidity coverage at 1.07x short-term liabilities, though inventory accumulation to 196.0B yen and prolonged receivables collection cycles present working capital management challenges.
Revenue declined 1.6% YoY to 603.8B yen, with external customer revenue across all three geographic segments showing modest contraction. The Japan segment generated external revenue of 269.7B yen (calculated as total segment revenue 500.2B yen minus inter-segment sales 230.5B yen), North America contributed 180.9B yen, and Europe delivered 183.0B yen. On a reported segment basis, Japan-Asia-Oceania segment revenue decreased 4.9% YoY to 500.2B yen, North America declined 1.6% to 180.9B yen, and Europe-Middle East-Africa fell 3.2% to 183.0B yen. Segment profit trends deteriorated more sharply, with Japan-Asia-Oceania segment profit declining 16.3% to 56.6B yen, while North America segment profit surged 146.3% to 6.8B yen and Europe segment profit fell 66.9% to 3.5B yen. After inter-segment eliminations, consolidated operating income reached 63.5B yen, down 14.5% YoY, indicating profit margin compression across the core Japan segment and Europe operations despite North America's recovery. The disproportionate decline in operating income relative to revenue reflects SG&A expense pressure at 233.5B yen (38.7% of revenue) and potential working capital related costs. Non-operating expenses net increased, with interest expense of 3.4B yen and foreign exchange losses of 0.2B yen contributing to a 3.4B yen negative non-operating balance, narrowing ordinary income to 60.0B yen. No material extraordinary items were recorded, with extraordinary income of 0.1B yen from asset sales and negligible extraordinary losses. The effective tax rate of 24.4% remained within normal range. Net income of 45.5B yen represented an 8.6% YoY decline, less severe than operating income due to proportionate tax effects. This represents a revenue down/profit down pattern, characterized by modest top-line contraction amplified by margin compression from cost structure inflexibility and operational inefficiencies.
The Japan-Asia-Oceania segment constitutes the core business, generating 500.2B yen in segment revenue (including 230.5B yen inter-segment) and 56.6B yen in segment profit, representing 84.6% of total segment profit. Segment profit margin for Japan-Asia-Oceania stood at 11.3%, compared to 3.8% for North America and 1.9% for Europe-Middle East-Africa, highlighting significant margin differentiation. The Japan segment experienced the largest absolute profit decline of 10.2B yen YoY despite being the highest margin business, indicating core market pressures or cost absorption challenges. North America achieved notable profit recovery with segment profit increasing 4.1B yen YoY to 6.8B yen on relatively stable revenue, suggesting operational improvements or product mix benefits. Europe segment profit deteriorated sharply by 7.0B yen to 3.5B yen, reflecting the most severe margin compression among regions and potentially indicating competitive pressures or currency headwinds in those markets. The wide margin disparity between Japan (11.3%) and overseas operations (North America 3.8%, Europe 1.9%) underscores the profit concentration in the domestic/Asia-Pacific region and the margin improvement opportunity in international markets.
[Profitability] ROE of 12.2% exceeds the company's prior year level and demonstrates strong equity returns, with operating margin of 10.5% representing a contraction from prior period levels due to SG&A expense burden. Gross profit margin maintained a robust 49.2%, indicating sustained pricing power and favorable product mix, while net profit margin of 7.5% reflects the cumulative impact of operating expense pressure and financial costs. Interest coverage ratio stood at approximately 18.6x, demonstrating ample debt servicing capacity. [Cash Quality] Cash and deposits totaled 172.4B yen, providing 0.45x coverage of short-term liabilities valued at 380.5B yen, while short-term debt concentration at 161.5B yen (85.2% of total interest-bearing debt) indicates refinancing risk exposure. [Investment Efficiency] Asset turnover of 0.749 indicates revenue generation efficiency, though inventory of 196.0B yen represents 24.3% of total assets and suggests capital tied up in working capital. Total assets increased to 806.4B yen from 761.7B yen, driven by current asset expansion. [Financial Health] Equity ratio of 46.1% reflects a moderately leveraged balance sheet, with total equity of 371.9B yen up from 323.7B yen YoY. Current ratio of 160.4% and quick ratio of 108.9% indicate adequate short-term liquidity, though the composition is skewed toward inventory rather than cash. Debt-to-equity ratio of 0.51 (calculated as interest-bearing debt 189.6B yen divided by equity 371.9B yen) remains within conservative boundaries. Long-term loans decreased to 28.1B yen from 39.7B yen, representing a 29.3% YoY decline, while short-term borrowings dominate the debt structure.
Cash and deposits increased 13.5B yen YoY to 172.4B yen, indicating cash accumulation despite profit decline, which suggests positive operating cash generation or financing inflows offsetting investing activities. Total assets expanded 44.7B yen to 806.4B yen, with current assets rising 40.2B yen to 610.4B yen, driven primarily by inventory increase of 21.5B yen to 196.0B yen and accounts receivable expansion, reflecting working capital absorption of cash. Inventories now represent 32.1% of current assets, up from 28.6% in the prior year, signaling inventory buildup either from demand softness or strategic stocking. Current liabilities increased 29.8B yen to 380.5B yen, with short-term borrowings rising 7.8B yen to 161.5B yen, suggesting incremental debt financing to support operations or refinancing of maturing long-term debt. Long-term debt declined 11.6B yen to 28.1B yen, indicating either repayment or reclassification to short-term, contributing to elevated short-term debt concentration. Equity increased 48.2B yen to 371.9B yen, driven by retained earnings accumulation of 45.5B yen net income less estimated dividend payments. The cash position of 172.4B yen provides 1.07x coverage of short-term debt of 161.5B yen, maintaining baseline liquidity adequacy, though the short-term debt ratio of 85.2% warrants monitoring for refinancing risk. Working capital efficiency appears strained with inventory days elongated and receivables collection extended, resulting in cash conversion cycle pressure that constrains free cash generation despite profitability.
Ordinary income of 60.0B yen versus operating income of 63.5B yen reflects a negative non-operating net contribution of approximately 3.5B yen, indicating net financial costs and other non-operating burdens. Non-operating income totaled 2.9B yen, comprising interest income of 0.7B yen and other non-operating income of 1.3B yen, while non-operating expenses reached 6.3B yen, primarily from interest expense of 3.4B yen, foreign exchange losses of 0.2B yen, and other expenses of 0.6B yen. The net non-operating burden of 3.4B yen represents 0.6% of revenue, a modest proportion that reflects controlled financial costs despite elevated debt levels. No significant extraordinary items impacted results, with extraordinary income of 0.1B yen from asset sales and negligible extraordinary losses, confirming that reported profits derive from core operations without material one-time gains or restructuring charges. The modest gap between operating and ordinary income, combined with absence of extraordinary items, indicates earnings are predominantly recurring in nature. However, without disclosed operating cash flow data, direct assessment of accruals quality is constrained. The balance sheet shows inventory accumulation and receivables growth outpacing revenue, suggesting potential accruals buildup that could indicate earnings quality concerns if working capital deterioration continues. The increase in product warranty reserves to 11.9B yen also warrants attention as a potential indicator of quality issues or conservative provisioning. Overall, earnings appear largely recurring with core profitability driving results, though working capital trends suggest cash realization lags accounting profits.
Full-year guidance remains unchanged at Revenue of 825.0B yen, Operating Income of 85.0B yen, Ordinary Income of 78.0B yen, and EPS of 190.10 yen. Progress rates through Q3 stand at 73.2% for revenue (603.8B/825.0B), 74.7% for operating income (63.5B/85.0B), and 76.9% for ordinary income (60.0B/78.0B), all tracking ahead of the standard 75% benchmark for Q3, indicating management expects a softer Q4 or has embedded conservatism in guidance. The operating income progression rate of 74.7% implies Q4 operating income of 21.5B yen, representing potential deceleration from Q3 run rates, though this may reflect typical seasonal patterns or planned investment timing. Net income through Q3 of 45.5B yen against implied full-year guidance (derivable from forecasted EPS of 190.10 yen times average shares of approximately 289.3 million) suggests expected full-year net income near 55.0B yen, implying Q4 net income of approximately 9.5B yen and an effective Q4 tax rate or one-time adjustment. The unchanged guidance despite Q3 underperformance in margins suggests management confidence in cost recovery or revenue acceleration in Q4, though risks to achieving targets appear elevated given operating margin pressure trends. Annual dividend forecast of 25.0 yen per share remains unchanged, representing expected total dividends of approximately 7.2B yen and a payout ratio of approximately 37% based on projected net income.
Annual dividend forecast stands at 25.0 yen per share, consisting of an interim dividend of 12.5 yen and year-end dividend of 12.5 yen, maintaining consistency with prior policy. Based on forecasted EPS of 190.10 yen, the payout ratio calculates to approximately 13.2%, though using actual trailing twelve-month EPS or full-year net income estimates near 55.0B yen yields a payout ratio closer to 37%, which appears more aligned with typical practice. The dividend of 25.0 yen per share applied to outstanding shares of approximately 28.9 million (32.0 million issued less 3.1 million treasury shares) implies total annual dividend payments of approximately 7.2B yen. Retained earnings at 257.8B yen provide substantial coverage for dividends, with a dividend coverage ratio exceeding 35x based on equity reserves. No share buyback programs were disclosed in the available data. Cash reserves of 172.4B yen and expected positive operating cash flow support dividend sustainability at current levels, though working capital absorption trends warrant monitoring for future cash availability. The total return ratio based on dividends alone approximates 37% of net income, leaving 63% for reinvestment or balance sheet strengthening, which appears prudent given working capital demands and short-term debt refinancing needs.
Inventory management risk: Inventory of 196.0B yen represents elevated levels with inventory turnover days estimated at 233 days, significantly exceeding industry norms and indicating potential obsolescence risk, pricing pressure, or demand-supply mismatches that could necessitate write-downs or margin-dilutive clearance sales. Refinancing and liquidity risk: Short-term borrowings of 161.5B yen comprise 85.2% of total interest-bearing debt, creating refinancing concentration risk if credit conditions tighten or operating cash flow weakens, despite current cash coverage of 1.07x short-term debt. Working capital efficiency deterioration: Receivables turnover days of 67 days combined with elongated inventory turnover results in a cash conversion cycle estimated at 359 days, constraining cash generation and potentially necessitating incremental external financing to fund operations.
[Industry Position] (Reference - Proprietary Analysis) Profitability: ROE of 12.2% substantially exceeds the manufacturing industry median of 5.8% (IQR: 3.1%-8.4%, n=105) for 2025-Q3, placing the company in the upper quartile and reflecting superior equity returns. Operating margin of 10.5% also surpasses the industry median of 8.9% (IQR: 5.4%-12.7%, n=105), confirming above-average operational profitability despite recent margin compression. Net profit margin of 7.5% exceeds the industry median of 6.5% (IQR: 3.3%-9.4%, n=105), further validating strong profitability positioning. Financial Health: Equity ratio of 46.1% falls below the industry median of 63.8% (IQR: 49.1%-74.8%, n=105), indicating more aggressive leverage utilization compared to peers and positioning the company in the lower half of the distribution. Current ratio of 160.4% (1.60x) significantly underperforms the industry median of 2.87x (IQR: 2.13x-3.84x, n=84), reflecting tighter liquidity management or higher working capital intensity relative to peers. Efficiency: Asset turnover of 0.749 exceeds the industry median of 0.56 (IQR: 0.41-0.65, n=105), demonstrating superior asset utilization efficiency and revenue generation per unit of assets deployed. However, inventory turnover days estimated at 233 days substantially exceed the industry median of 112 days (IQR: 50-163 days, n=97), highlighting inventory management as a relative weakness. Receivables turnover days of 67 days fall within the lower range compared to the industry median of 85 days (IQR: 69-117 days, n=104), indicating relatively efficient collection practices. Growth: Revenue contraction of -1.6% YoY compares unfavorably to the industry median growth of +2.8% (IQR: -1.5% to +8.8%, n=105), placing the company below median in top-line expansion. EPS decline of -8.9% YoY underperforms the industry median EPS growth of +9% (IQR: -20% to +33%, n=104), reflecting both revenue and margin pressures relative to peers. Return Metrics: Return on Assets of approximately 5.6% (calculated as net income 45.5B/total assets 806.4B) exceeds the industry median ROA of 3.4% (IQR: 1.8%-5.2%, n=105), indicating strong asset-level profitability. Financial leverage of 2.17x surpasses the industry median of 1.53x (IQR: 1.31-1.86, n=105), confirming more aggressive capital structure deployment to amplify equity returns.
(Industry: Manufacturing (n=105 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis)
Superior profitability metrics with ROE of 12.2% and operating margin of 10.5% both exceeding industry medians position the company as a high-return business within the manufacturing sector, though current year margin deterioration of 14.5% in operating income on modest revenue decline of 1.6% signals operating leverage challenges requiring management attention to cost structure and pricing dynamics. Working capital management emerges as the critical near-term focus, with inventory levels at 196.0B yen and estimated inventory days of 233 substantially exceeding the industry median of 112 days, creating cash conversion cycle pressure and potential obsolescence risk that constrains free cash generation despite strong profitability. The capital structure characterized by 85.2% short-term debt concentration against total interest-bearing debt presents refinancing risk, though cash coverage of 1.07x short-term liabilities and interest coverage of 18.6x provide near-term financial flexibility, making debt maturity extension a strategic priority to enhance balance sheet resilience.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.